Abstract:Background: Beta-cell replacement methods such as transplantation of isolated donor islets have been proposed as a curative treatment of type 1 diabetes, but widespread application is challenging due to shortages of donor tissue and the need for continuous immunosuppressive treatments. Stem-cell-derived islets have been suggested as an alternative source of beta cells, but face transplantation protocols optimization difficulties, mainly due to a lack of available methods and markers to directly monitor grafts survival, as well as their localization and function. Molecular imaging techniques and particularly positron emission tomography has been suggested as a tool for monitoring the fate of islets after clinical transplantation. The integral membrane protein DGCR2 has been demonstrated to be a potential pancreatic islet biomarker, with specific expression on insulin-positive human embryonic stem-cell-derived pancreatic progenitor cells. The candidate Affibody molecule ZDGCR2:AM106 was radiolabeled with fluorine-18 using a novel click chemistry-based approach. The resulting positron emission tomography tracer [18F]ZDGCR2:AM106 was evaluated for binding to recombinant human DGCR2 and cryosections of stem-cell-derived islets, as well as in vivo using an immune-deficient mouse model transplanted with stem-cell-derived islets. Biodistribution of the [18F]ZDGCR2:AM106 was also assessed in healthy rats and pigs. Results: [18F]ZDGCR2:AM106 was successfully synthesized with high radiochemical purity and yield via a pretargeting approach. [18F]ZDGCR2:AM106 retained binding to recombinant human DCGR2 as well as to cryosectioned stem-cell-derived islets, but in vivo binding to native pancreatic tissue in both rat and pig was low. However, in vivo uptake of [18F]ZDGCR2:AM106 in stem-cell-derived islets transplanted in the immunodeficient mice was observed, albeit only within the early imaging frames after injection of the radiotracer. Conclusion: Targeting of DGCR2 is a promising approach for in vivo detection of stem-cell-derived islets grafts by molecular imaging. The synthesis of [18F]ZDGCR2:AM106 was successfully performed via a pretargeting method to label a site-specific covalently bonded fluorine-18 to the Affibody molecule. However, the rapid washout of [18F]ZDGCR2:AM106 from the stem-cell-derived islets graft indicates that dissociation kinetics can be improved. Further studies using alternative binders of similar classes with improved binding potential are warranted.

RNA aptamers specific for transmembrane p24 trafficking protein 6 and Clusterin for the targeted delivery of imaging reagents and RNA therapeutics to human β cells

In Vivo Targeted Delivery of ANGPTL8 Gene for Beta Cell Regeneration in Rats

RNA-Based Aptamer Targeting Clusterin Protein as a Diabetes Biomarker

RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule

In Silico Design and Validation of High-Affinity RNA Aptamers Targeting Epithelial Cellular Adhesion Molecule Dimers

Rapid Identification of Cell-Specific, Internalizing RNA Aptamers with Bioinformatics Analyses of a Cell-Based Aptamer Selection

In Vivo Fluorescence Imaging of Tumors Using Molecular Aptamers Generated by Cell-Selex

Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells

Identification and Validation of a New Peptide Targeting Pancreatic Beta Cells

Identification of In Vivo Internalizing Cardiac-Specific RNA Aptamers

Selection and identification of a prohibitin 2-binding DNA aptamer for tumor tissue imaging and targeted chemotherapy

Selection of a Nuclease-Resistant RNA Aptamer Targeting CD19

Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapy

In silico analysis of aptamer-RNA conjugate interactions with human transferrin receptor

Selection of internalizing RNA aptamers into human breast cancer cells derived from primary sites

Aptamers from Cell-based Selection for Bioanalysis and Bioimaging

Aptamer-functionalized silver nanoclusters-mediated cell type-specific siRNA delivery and tracking

Targeted quantum dots fluorescence probes functionalized with aptamer and peptide for transferrin receptor on tumor cells.

Noninvasive Visualization Of Rna Delivery With Tc-99m-Radiolabeled Small Interference Rna In Tumor Xenografts

An shRNA screen in primary human beta cells identifies the serotonin 1F receptor as a negative regulator of survival during transplant

Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras